We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$478B
AUM Growth
+$50B
Cap. Flow
+$13.3B
Cap. Flow %
2.79%
Top 10 Hldgs %
18.61%
Holding
4,322
New
132
Increased
3,091
Reduced
523
Closed
113

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$848M
2
BMY icon
Bristol-Myers Squibb
BMY
+$631M
3
TFC icon
Truist Financial
TFC
+$445M
4
AMZN icon
Amazon
AMZN
+$334M
5
NOW icon
ServiceNow
NOW
+$251M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Financials 15.45%
3 Healthcare 13.87%
4 Consumer Discretionary 9.9%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMD
3651
Western Asset Emerging Markets Debt Fund
EMD
$611M
$275K ﹤0.01%
19,275
-58,803
-75% -$822K
VERO
3652
DELISTED
Venus Concept
VERO
$275K ﹤0.01%
355
+340
+2,267% +$291K
FEIM icon
3653
Frequency Electronics
FEIM
$591M
$272K ﹤0.01%
26,666
+350
+1% +$3.75K
ASXC
3654
DELISTED
Asensus Surgical, Inc.
ASXC
$272K ﹤0.01%
185,601
+5,947
+3% +$20.7K
HTGM
3655
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$270K ﹤0.01%
2,142
+788
+58% +$107K
SONM icon
3656
DNA X Inc
SONM
$4.84M
$268K ﹤0.01%
41
+18
+78% +$88.8K
APTX
3657
DELISTED
Aptinyx Inc. Common Stock
APTX
$267K ﹤0.01%
78,262
-1,245
-2% -$4.29K
SAEX
3658
DELISTED
SAExploration Holdings, Inc.
SAEX
$267K ﹤0.01%
88,060
+59,432
+208% +$137K
PRTS icon
3659
CarParts.com
PRTS
$42.4M
$264K ﹤0.01%
12,024
+1,195
+11% +$23.2K
CGEN icon
3660
Compugen
CGEN
$220M
$263K ﹤0.01%
44,192
IAG icon
3661
IAMGOLD
IAG
$8.42B
$263K ﹤0.01%
70,673
+25,260
+56% +$89.3K
DSKEW
3662
DELISTED
Daseke, Inc. Warrant
DSKEW
$262K ﹤0.01%
2,222,892
NTWK icon
3663
NetSol Technologies
NTWK
$50.8M
$260K ﹤0.01%
65,214
+316
+0.5% +$1.46K
CZWI icon
3664
Citizens Community Bancorp
CZWI
$211M
$259K ﹤0.01%
21,213
+1,765
+9% +$20.5K
ASA
3665
ASA Gold and Precious Metals
ASA
$955M
$257K ﹤0.01%
18,914
-13,122
-41% -$163K
ECOR icon
3666
electroCore
ECOR
$56.7M
$256K ﹤0.01%
10,783
+2,336
+28% +$59.5K
NWG icon
3667
NatWest
NWG
$73.7B
$255K ﹤0.01%
36,987
-28,995
-44% -$182K
MACK
3668
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$255K ﹤0.01%
81,147
+249
+0.3% +$997
MT icon
3669
ArcelorMittal
MT
$52.3B
$254K ﹤0.01%
14,556
-4,604
-24% -$74.6K
AUTL
3670
Autolus Therapeutics
AUTL
$407M
$252K ﹤0.01%
19,145
+7,813
+69% +$102K
XENE icon
3671
Xenon Pharmaceuticals
XENE
$6.2B
$252K ﹤0.01%
19,242
LSAK icon
3672
Lesaka Technologies
LSAK
$399M
$251K ﹤0.01%
67,545
+30,847
+84% +$102K
MOR
3673
DELISTED
MorphoSys AG American Depositary Shares
MOR
$251K ﹤0.01%
+7,049
New +$211K
GSH
3674
DELISTED
Guangshen Railway Co. Ltd
GSH
$251K ﹤0.01%
+15,176
New +$245K
CPIX icon
3675
Cumberland Pharmaceuticals
CPIX
$101M
$250K ﹤0.01%
48,610

Similar funds

Geode Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
  • Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
  • Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
  • Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
  • Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
  • Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
  • Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.

Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.